Eli
-
USA
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Small | Reuters Market share of India’s most popular weight…
Read More » -
USA
Eli Lilly opposes Trump MFN drug pricing law, CEO Ricks says
Dave Ricks, CEO of Eli Lilly, speaks in the Oval Office during an event about weight loss medications at the…
Read More » -
USA
Eli Lilly GLP-1 pill Foundayo approved for obesity
US Food and Drug Administration approved Eli LillyThe company said the GLP-1 pill is a major milestone for the Indianapolis-based…
Read More » -
USA
Eli Lilly to acquire Centessa and sleep disorder drugs
Lilly President and CEO Dave Ricks speaks at a press conference on behalf of Eli Lilly and Company in Houston,…
Read More » -
USA
Eli Lilly reaches deal to bring AI-developed drugs to global market
A drone image of the Eli Lilly logo is seen at the company’s office in San Diego, California, on November…
Read More » -
USA
Eli Lilly’s new shot shows solid weight loss in study — plus, a way for Nvidia to perk up
Every weekday, CNBC Investment Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap…
Read More » -
USA
Eli Lilly’s obesity drug retatrutide clears late-stage diabetes trial
The Eli Lilly logo is seen at the company’s office in San Diego, California, USA on November 21, 2025. Mike…
Read More » -
USA
Eli Lilly is ready for obesity pill approval from FDA
Every weekday, CNBC Investment Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap…
Read More » -
USA
Eli Lilly launches program to boost employer coverage of obesity drugs
Eli Lilly On Thursday, the U.S. launched a new program designed to help more employers cover obesity medications, aiming to…
Read More » -
USA
Eli Lilly launches Zepbound obesity drug pen with one month of doses
An Eli Lilly & Co. issued in the Brooklyn borough of New York on March 28, 2024. Zepbound injection pen.…
Read More »